Replimune Group, Inc.
REPL
$9.27
$0.222.43%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 35.28% | 33.54% | 37.33% | 49.52% | 28.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.42% | 8.44% | 23.83% | 33.70% | 48.17% |
| Operating Income | -5.42% | -8.44% | -23.83% | -33.70% | -48.17% |
| Income Before Tax | -8.86% | -7.25% | -21.37% | -23.79% | -33.47% |
| Income Tax Expenses | -32.98% | 41.67% | -57.67% | 41.67% | -- |
| Earnings from Continuing Operations | -8.71% | -7.30% | -21.16% | -23.82% | -33.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.71% | -7.30% | -21.16% | -23.82% | -33.95% |
| EBIT | -5.42% | -8.44% | -23.83% | -33.70% | -48.17% |
| EBITDA | -5.28% | -9.29% | -25.21% | -35.52% | -50.78% |
| EPS Basic | -2.81% | -2.44% | -10.66% | -8.10% | -10.71% |
| Normalized Basic EPS | -2.97% | -2.39% | -10.83% | -8.06% | -10.31% |
| EPS Diluted | -2.81% | -2.44% | -10.66% | -8.10% | -10.71% |
| Normalized Diluted EPS | -2.97% | -2.39% | -10.83% | -8.06% | -10.31% |
| Average Basic Shares Outstanding | 5.57% | 5.15% | 9.48% | 14.36% | 21.07% |
| Average Diluted Shares Outstanding | 5.57% | 5.15% | 9.48% | 14.36% | 21.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |